Traditional glaucoma surgery in the era of MIGS procedures
Trabeculectomy may offer better results with more severe glaucoma
Apps now online to aid patients with visual impairment
Technology is off to a good start, but improvements still needed
IOP homeostasis in glaucoma: Looking below the surface
New research is looking past just regulating the IOP, using a single-cell RNA to identify 12 distinct cell types in trabecular meshwork.
OCTA: The jury is still out
Diagnostic and monitoring advances in glaucoma need fine-tuning
Funding new technologies for glaucoma treatment
With an eye on innovation, money is driving research of new therapies and devices.
Pearls for managing COVID-19 pandemic north of the border
Canadian ophthalmologists receive updates on best practices amid coronavirus outbreak
Glaucoma drug delivery devices enter new frontier
Industry develops creative approaches to help increase patient medication adherence
Glaucoma devices: Now and in the future
Panel discusses IOP monitoring, drug delivery, data collection
Investigators target algorithm for diagnosing glaucoma
Research finds automated segmentation software examines OCT scans
Glaucoma 360: Lowering IOP using the MIMS solution
ICYMI: Nir Israeli, co-founder and CEO of Sanoculis discusses the company's new alternative surgical procedure for glaucoma designed to create a single-patient-use sterile tool and a multi-use external machine.
Beating burnout with camaraderie
For many physicians, “moral injury” may be actual issue
Glaucoma 360: Drug delivery contact lens technology
ICYMI: Chris Adams, CEO of Diopter Corp, discusses the company's drug delivery contact lens technology in the pipeline that works to treat ocular surface disease, during the 2020 Glaucoma 360 meeting in San Francisco, California.
Glaucoma 360: Pharmaceuticals in the glaucoma industry
ICYMI: Ramin Valian, vice president of International Glaucoma, Reimbursement and Pipeline at Allergan, discusses glaucoma from a therapeutics/diagnostics and big data sets standpoint during the 2020 Glaucoma 360 meeting.
Status of glaucoma: diagnostics and treatments in flux
High-level observations for how the latest developments can help glaucoma specialists solve problems to achieve the utmost in patient care
Next frontier in glaucoma: Beyond IOP-lowering treatments
Besides traditional medications, here are some of the many novel approaches to treat patients with glaucoma
Normal tension glaucoma: testing diagnostic skills
There are other mimickers of NTG that should be kept in mind
Diagnostics: Innovative ways of looking at glaucoma
New products increase the chance of early diagnosis
Glaucoma 360: Accessible glaucoma care in 1 second (BELKIN Laser)
ICYMI: Daria Lemann Blumenthal, CEO of BELKIN Laser, Ltd., discusses the company's current initiative of developing an automated one-second laser therapy for glaucoma called direct selective laser trabeculoplasty (DSLT).
Glaucoma medications: Getting down to the basics
New therapies on the horizon offer options for slowing progression
Study targets results of MIGS device versus trabeculectomy
Glaucoma 360: Apps for the visually challenged
ICYMI: Yvonne Ou, MD, discusses her presentation on "Apps for the visually challenged," during the 2020 Glaucoma 360 annual meeting in San Francisco, California.
Study targets topical medication adherence, visual field progression
Research is seeking benefits, options for open-angle glaucoma patients
Glaucoma devices provide impressive IOP-lowering results
Novel technologies range from invasive to non-invasive approaches
Glaucoma 360: Risk factors for glaucoma progression
Dale Heuer, MD discusses the importance of ophthalmologists identifying and providing more aggressive treatment care for patients with low/high risks of developing glaucoma.
Surgeons discuss MIPS, impact of pass-through medications
Bonuses are the norm and not risked by pass-through medication use
Glaucoma 360: Decision-making in surgical glaucoma
ICYMI: Thomas Samuelson, MD,shares the key highlights from his presentation "Stents, trabs, and tubes: Decision-making in surgical glaucoma."
Glaucoma 360: Update on OCT-A in glaucoma
ICYMI: Robert Stamper, MD, offers an update on optical coherence tomography angiography in glaucoma during the 2020 Glaucoma 360 annual meeting.
Glaucoma treatment alternatives: Thinking outside the box
Treatment options may expand beyond surgery, medication, and lasers
Glaucoma 360: Is normal-tension glaucoma normal?
ARVO 2020: OCT-A vs laser speckle contrast imaging
2 Clarke Drive Cranbury, NJ 08512